ロード中...
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
SIMPLE SUMMARY: HER2 testing in endometrial cancer (EC) has gained renewed interest as a therapeutic target. However, HER2 status has not been investigated in the context of the molecular EC classification. Here, we aimed to determine the clinicopathological features and prognostic significance of t...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7795222/ https://ncbi.nlm.nih.gov/pubmed/33375706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010044 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|